Our Tech Can Turn Plastic Waste Into A Source of Renewable Energy
Our proprietary Advanced BioRecycle™ technology accelerates the natural degradation process from centuries to just a few years for all Midori Bio treated plastics in landfills including problematic and single-use. This ultimately creates a source of renewable energy.
Don't miss this opportunity to become a shareholder of a high-growth company as we continue to onboard leading CPG brands and target a go-public NASDAQ listing.
The Plastic Waste Crisis Is Costing Us Billions
Every year, 380 million tons of plastic¹ are produced worldwide, with only a staggering 9% of plastic waste being recycled. Even items that display the recycling symbol, like plastic films and milk jugs, often fail to meet recycling standards and end up in landfills. The value of unrecycled plastic waste is estimated to be in the billions, burdening our planet and our economy. We’re transforming this problem into a massive opportunity for brands and investors.
The future of plastic waste is energy. Will you be part of it?
Advanced BioRecycle™ Accelerates the Reduction of Treated Plastic Waste in Landfills
Our Advanced BioRecycle™ technology additive that seamlessly integrates into existing plastic manufacturing processes. It enables plastic to create a source of renewable energy in landfills and marine environments.
No Manufacturing Changes:
The additive is introduced exactly like a normal colour additive, with no modifications needed to existing plastic production processes.
Recyclable & Circular:
The additive doesn’t interfere with existing recycling processes—plastic waste can still be recycled as normal. Does not require any change to the current plastic waste collection process.
Renewable Energy Gains:
During decomposition, about 75% of the plastic turns into biogas that can be harnessed. The remaining 25% becomes inert humus, a natural soil-like substance. Governments and Landfill Gas businesses agree that an additive like Midori could help unlock additional renewable energy to the grid.
Third Party Tested and FDA-Compliant:
Unlike costly alternatives such as bioplastics or post-consumer recycled plastic, our Advanced BioRecyclable TM additive is organic, is third party tested and FDA-compliant, and requires no changes to standard operating procedures.
Global Standards & Approvals:
Get The Investor Deck
Robust Pipeline of Leading Global Brands
Successful onboarding by large CPGs has proven Midori Bio's effectiveness for problematic plastics, paving the way for positive global impact.
Global Brands Are Already Onboard
We’ve already secured partnerships with industry leaders like:
.avif)
in addition to other tennis, pickleball, footwear, airline and food companies
Demand Is Growing Rapidly
Over 150 brands and industrial extruders are currently in our pipeline for potential onboarding.
Over 400M Metric Tons of Plastic Is Made Every Year²
Each sector we target presents a multi-million dollar opportunity as we address the world’s most pressing sustainability challenges. Here are just a few
Footwear: Up to 24 billion pairs of shoes made annually
Less than 1% is recycled
Sports: 50M in Revenue Potential
Tennis balls and golf grips that traditionally end up in landfills.
Food: 250M in Revenue Potential
We’re already preparing to launch with four major food brands.
A Nasdaq Listing on the Horizon
As we gear up for a Nasdaq listing we’re also scaling our technology across new markets like industrial packaging and durable goods. With over CAD $400 million in total addressable market, our growth trajectory is clear, and we’re ready to make a lasting impact on global plastic waste.
The Reg A will help accelerate growth and establish a methodical go public plan.
Meet the Visionaries Behind Our Solution
Ken Lyons, CEO and Co-Founder of Midori-Bio Inc. (founded in 2021), brings over 35 years of experience building major global brands. He has a proven track record in sales, marketing, and packaging solutions for top companies like SC Johnson Wax and Maple Leaf Foods, with deep expertise in consumer packaged goods (CPG) distribution and packaging.
Robert Leeder, Chairman and President of Midori-Bio Inc. (co-founded in 2021), has over 30 years of executive leadership in global brands. He has successfully led financial, marketing, and operational advancements for companies like Titan and Easton Sports. Over the past 12 years, he has introduced sustainable, toxin-free additives to help brands reduce their carbon footprint.
Get The Investor Deck
Frequently Asked Questions
Click here to see all of Midori’s regulatory filings, including financial reports.
$20M
Investing in startups is risky and there is no guarantee you will get a return on your investment. However, an exit opens up the opportunity where you could convert your shares into cash or a more liquid asset. Exits include going public, getting acquired by a larger company, or our company buying back shares. If the value of our company grows, then you have a higher potential of making a profit on your investment during one of these exits. Future liquidation events could include an acquisition or IPO.
Shares will be rewarded after the investment funds clear. This typically takes around 3 weeks after investment.
No, costs are the same, regardless of how you invest
We will use funds to continue to scale up given our new customer expansion including inventory production, marketing, sales, continued R&D, and new innovation opportunities.
$22M USD.
You are investing in innovative technology that provides business and governments a pragmatic, cost-effective tool to manage landfill plastic waste without eliminating the benefits that plastic products provide.
Company is currently near cash flow neutral and anticipates current revenues are sufficient to discharge liabilities as they come due.
Midori will become cashflow positive by Q4 2026, with the business anticipated to scale significantly in the years following. Midori will provide liquidity to shareholders via either a public listing or sale to a strategic buyer.
We are focused on Sporting Goods, Footwear and Consumer Packaging Goods products and packaging as they are considered problematic plastic that have limited or no end-of-life pathway as recycling isn’t effective.
Over 200 investors.
No
We are located in the heart of Toronto’s Ontario Canada’s business/financial district.
We have a lean organization of 13 members, not including our manufacturing team.
Midori to become cashflow positive by Q4 2026, to drive this Midori will be scaling sales with existing customers, as well as expanding to different verticals outside of the current customer base while keeping fixed costs low with revenue outpacing expenses.
This industry focuses on “trade secrets” vs patents as it is more confidential and easier to defend our IP.
We focus on leading global brands at the “C” suite level, along with government entities and plastic producers.
Where we feel there is an exponential and synergistic benefit to the business and shareholders.
Midori Bio’s Advanced Biorecycle™ is an innovative technology that requires third party test data results and stakeholder education. We now have the data required to meet that “Brands” internal checklist to move forward on key target channels and products we know have the greatest need for our technology.